- Home
- ATAI vs LIEN Comparison
ATAI vs LIEN Comparison
Compare ATAI & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- LIEN
- Stock Information
- Founded
- ATAI 2018
- LIEN 2021
- Country
- ATAI Germany
- LIEN United States
- Employees
- ATAI N/A
- LIEN N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- LIEN
- Sector
- ATAI Health Care
- LIEN
- Exchange
- ATAI Nasdaq
- LIEN NYSE
- Market Cap
- ATAI 271.6M
- LIEN 264.8M
- IPO Year
- ATAI 2021
- LIEN 2022
- Fundamental
- Price
- ATAI $1.41
- LIEN $11.64
- Analyst Decision
- ATAI Strong Buy
- LIEN
- Analyst Count
- ATAI 4
- LIEN 0
- Target Price
- ATAI $9.00
- LIEN N/A
- AVG Volume (30 Days)
- ATAI 2.1M
- LIEN 10.3K
- Earning Date
- ATAI 03-17-2025
- LIEN 05-08-2025
- Dividend Yield
- ATAI N/A
- LIEN 12.03%
- EPS Growth
- ATAI N/A
- LIEN N/A
- EPS
- ATAI N/A
- LIEN 0.67
- Revenue
- ATAI $308,000.00
- LIEN $12,681,914.00
- Revenue This Year
- ATAI N/A
- LIEN $71.81
- Revenue Next Year
- ATAI $20.00
- LIEN $113.93
- P/E Ratio
- ATAI N/A
- LIEN $17.20
- Revenue Growth
- ATAI N/A
- LIEN 22.94
- 52 Week Low
- ATAI $0.78
- LIEN $8.38
- 52 Week High
- ATAI $2.85
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- ATAI 39.19
- LIEN N/A
- Support Level
- ATAI $1.34
- LIEN N/A
- Resistance Level
- ATAI $1.52
- LIEN N/A
- Average True Range (ATR)
- ATAI 0.11
- LIEN 0.00
- MACD
- ATAI -0.02
- LIEN 0.00
- Stochastic Oscillator
- ATAI 16.87
- LIEN 0.00
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company's investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies.